Important of case-reports/series, in rare diseases: Using neuroendocrine tumors as an example  被引量:1

Important of case-reports/series, in rare diseases: Using neuroendocrine tumors as an example

在线阅读下载全文

作  者:Taichi Nakamura Hisato Igarashi Tetsuhide Ito Robert T Jensen 

机构地区:[1]Cell Biology Section,NIDDK, National Institutes of Health, Bethesda, Maryland, MD 20814, United States [2]Department of Medicine and Bioregulatory Science,Kyushu University,Fukuoka 812-8581,Japan

出  处:《World Journal of Clinical Cases》2014年第11期608-613,共6页世界临床病例杂志

基  金:Supported by Intramural Research Funds of NIDDK,NIH

摘  要:At present the publishing of case reports or case series involving small numbers of cases is controversial. While in the past they were commonly published by most journals, recently a number of prominent journals have either stopped publishing them or markedly reduced the numbers published. However, recently an increasing case is being made for their value and a number of new journals have been started devoted specifically to their publication. One of the arguments used for their value is their prominent role in rare diseases either in their recognition, full description or development of treatments. However this aspect has not been specifically studied. In this editorial this aspect is specifically examined using their role in neuroendocrine tumors as an example. Furthermore, the background of the controversy is briefly reviewed to better understand the context of this editorial.At present the publishing of case reports or case series involving small numbers of cases is controversial. While in the past they were commonly published by most journals, recently a number of prominent journals have either stopped publishing them or markedly reduced the numbers published. However, recently an increasing case is being made for their value and a number of new journals have been started devoted specifically to their publication. One of the arguments used for their value is their prominent role in rare diseases either in their recognition, full description or development of treatments. However this aspect has not been specifically studied. In this editorial this aspect is specifically examined using their role in neuroendocrine tumors as an example. Furthermore, the background of the controversy is briefly reviewed to better understand the context of this editorial.

关 键 词:CASE report CASE SERIES NEUROENDOCRINE TUMORS CARCINOIDS PANCREATIC NEUROENDOCRINE tumor 

分 类 号:R739.4[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象